SS-31
Warnings. Investigational drug; not approved. Injection-site reactions reported in trials.
Mechanism
Selectively binds cardiolipin to stabilize mitochondrial cristae architecture, improving electron transport chain efficiency and reducing reactive oxygen species production.
Overview
SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane. It improves mitochondrial efficiency, reduces oxidative stress, and is being studied for heart failure, mitochondrial myopathies, and age-related functional decline.
Protocols
Mitochondrial Support Cycle
Official
ADVANCED
Daily dosing for 30 days to support mitochondrial function.
Goal: Mitochondrial health and energy
Step 1 4.3w
4 mg · 1×/day · Morning
4mg once daily for 30 days.